Physician Profile
Mark A. Willoughby, M.D. practices dermatology in Chula Vista, CA. Mark is a 1997 graduate of Ohio State University College of Medicine. Medicare claims data shows Mark provided 22,529 services to 3,488 patients. The services billed most often include aminolevulinic acid hcl for topical administration, 10% gel, 10 mg, established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more, and destruction of precancer skin growth, 2-14 growths.
Summarised automatically from public NPI registry and CMS Medicare data. Not written or reviewed by this provider. Claim this profile to replace it.
Source: NPPES NPI Registry
319 F ST STE 102
Chula Vista, CA 91910
Within Dermatology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Most searched conditions
Acne and follicular disorders
Eczema and inflammatory skin disease
Infections and infestations
Pigment, growths, and benign lesions
Skin cancer
Urticaria, itch, and vascular
Autoimmune and connective tissue
Infections
Rashes & allergy
Skin growths
Most searched procedures
Diagnostic procedures
Lesion treatment
Medical dermatology treatment
Cosmetic
Cosmetic and minor surgery
Cosmetic dermatology
Diagnostic
General dermatology
Infections
Medical dermatology
Nails & hair
Skin cancer surgery
Skin growths
22,529 services · 3,488 patients · 24 distinct codes
| Procedure | Type | Code | Services |
|---|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | Procedure | 17003 |
1,164 |
| Biopsy of related skin growth, first growth | Procedure | 11102 |
495 |
| Destruction of precancer skin growth, 1 growth | Procedure | 17000 |
440 |
| Destruction of precancer skin growth, 15 or more growths | Procedure | 17004 |
209 |
| Biopsy of related skin growth, each additional growth | Procedure | 11103 |
137 |
| Injection into skin growth, more than 7 growths | Procedure | 11901 |
51 |
| Injection into skin growth, 1-7 growths | Procedure | 11900 |
51 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Procedure | 12032 |
30 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Procedure | 11602 |
29 |
| Complicated repair of wound of trunk, 2.6-7.5 cm | Procedure | 13101 |
28 |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Mark A. Willoughby is a dermatologist (skin doctor) in Chula Vista, CA. That is the designation recorded for this NPI in the federal registry, where it is listed as “Dermatology”.
NPI registry
Mark A. Willoughby is listed at 319 F St Ste 102, Chula Vista, CA 91910. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (619) 476-1200. Guide.md cannot book appointments or pass on messages — please call the office directly.
NPI registry
Mark A. Willoughby's National Provider Identifier is 1215931993. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Mark A. Willoughby attended Ohio State University College of Medicine, graduating in 1997. This comes from the CMS National Downloadable File.
CMS public data
Mark A. Willoughby has 29 years experience. Calculated from a graduation year of 1997, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, Mark A. Willoughby performs procedures including destruction of precancer skin growth, 2-14 growths, biopsy of related skin growth, first growth and destruction of precancer skin growth, 1 growth; reads or performs imaging such as obtaining data needed to develop the optimal radiation treatment, 1 treatment area and use of externally generated heat to increase temperature of cancer cell, heating to depths 4.0 cm or less; provides treatments such as application of ultraviolet light to skin and application of light with debridement to destroy precancer skin growth, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by Mark A. Willoughby. If this is you, claiming it is free.
Guide.md
Provider data sourced from the NPPES NPI Registry and CMS public datasets. Information is provided for reference and is not medical advice.